Today: 9 June 2026
Caledonian Holdings (CHP.L) pops on 11 November: price crosses key averages; no new RNS as AlbaCo deal continues to set the tone
11 November 2025
4 mins read

Caledonian Holdings (CHP.L) pops on 11 November: price crosses key averages; no new RNS as AlbaCo deal continues to set the tone

Dateline: London — 11 November 2025 (14:50 GMT)

Summary: Micro‑cap investor Caledonian Holdings plc (AIM: CHP) traded firmly higher today, with the share price up around 33% to 0.004p by mid‑afternoon. The move came without any fresh regulatory announcements; instead, momentum appears to reflect the market’s ongoing digestion of October’s AlbaCo share‑swap and last week’s admission of 12.5 billion new shares, alongside a buoyant London market on rate‑cut hopes.


Key takeaways for 11 Nov 2025

  • Price action: By 14:50 GMT, CHP traded at 0.004p, up +33.33% day‑on‑day; intraday, the price rose above both the 50‑day and 200‑day moving averages this morning and afternoon, reinforcing near‑term momentum signals.
  • No new filings today: There were no new RNS announcements for CHP on 11 Nov at the time of writing; the latest company notices remain the 31 Oct “Further investment in AlbaCo” and related share‑swap disclosures. Investegate+1
  • Recent capital move now effective: On 5 Nov, AIM admitted 12,500,000,000 new CHP ordinary shares (0.001p each), the consideration shares tied to the AlbaCo transaction. Post‑admission, total voting rights were set at 115,767,796,702.
  • Backdrop helps: Broader London equities rallied today after UK jobs data boosted hopes of a Bank of England rate cut in December; the FTSE 100 set a fresh intraday record and risk appetite improved across the market.

What moved CHP.L today

Technical tailwinds. With no new company‑specific news, traders focused on tape action. CHP printed 0.004p (+33% vs. prior close), with automated signals flagging crosses above the 50‑DMA (c. 08:08 GMT) and 200‑DMA (c. 12:44 GMT). For a sub‑penny AIM name, these triggers can attract short‑term momentum flows and market‑maker interest.

Macro risk‑on. UK stocks were broadly higher after data showing a rise in unemployment to 5% and easing wage growth increased the odds of a BoE cut; FTSE 100 notched a new intraday high. Such sessions typically improve liquidity and risk appetite in micro‑caps, even when correlations are loose.


The latest company news investors are still trading on

  • 31 Oct – Further investment in AlbaCo via share‑swap. Caledonian entered a binding agreement with Moulsdale Investments and Nevis Investments to exchange 500,000 AlbaCo shares (valued at £1.00 each) for 12.5 billion new CHP shares at 0.0040p—a 45.45% premium to the prior close—lifting Caledonian’s holding to ~5.47% of AlbaCo. Management also said it would stop quarterly investment updates in favour of ad‑hoc RNS.
  • 5 Nov – Admission of consideration shares. AIM formally admitted 12.5 billion new CHP shares, completing the mechanical leg of the AlbaCo swap.
  • 19 Sep – Fundraising update tied to AlbaCo’s regulatory capital raise. Caledonian reiterated that its planned follow‑on investment was conditional on AlbaCo raising at least £25 million of regulatory capital, and that it was prioritising institutional/structured capital engagement.
  • 30 Sep – Final results FY to 31 Mar 2025. Reported a £4.37 m loss driven largely by fair‑value movements; net assets stood at £2.87 m and cash increased following fundraises; disclosure also noted £1.0 m committed to AlbaCo across stages.
  • 11 Aug – Holding in company. Notification that John Story held ~19.67% following the July placing. (Significant holders matter in thinly‑traded micro‑caps.)
  • Brand transition (spring 2025). The company’s rebrand from Vela Technologies plc to Caledonian Holdings plc became effective 24 Mar 2025 and the ticker changed to CHP.

Price & liquidity snapshot (today)

  • Last price:0.004p (14:50 GMT), high 0.004p / low 0.0035p; shares traded ~777m by mid‑session. Shares outstanding now c. 115.77 bn; free float c. 76.02 bn. (Data delayed ~20 mins.)
  • External quote pages for retail investors also show CHP as a micro‑cap name, typically sub‑£5 m market value depending on intraday price.

Important: As of 11 Nov 2025, there were no fresh CHP RNS filings beyond those listed above; today’s move is price‑led rather than news‑led.


Why the AlbaCo exposure matters

Caledonian’s revised policy targets financial‑services assets (fintech, asset management, insurance, banking). AlbaCo is pursuing UK regulatory approvals for a specialist SME‑focused bank; Caledonian’s equity exposure rose to ~5.47% via the Oct share‑swap, and its earlier fundraising messaging explicitly tied further commitments to AlbaCo’s £25 m capital plan. Progress (or delays) at AlbaCo is therefore a key swing factor for CHP sentiment.


What to watch next

  1. Regulatory milestones at AlbaCo: Any update on authorisation progress or capital raised could be price‑moving for CHP.
  2. RNS cadence: After dropping quarterly portfolio updates, ad‑hoc RNS about investee developments and any further stake‑building are the main news catalysts.
  3. Market structure/volume: With ~115.77 bn shares in issue and a very low absolute price, even modest order flow can swing prints; watch liquidity and market‑maker behaviour on active days.
  4. Macro driver: A BoE cut (or a shift in expectations) can support risk appetite across UK small‑caps; the FTSE’s record run today reflects that backdrop.

Company in brief

Caledonian Holdings plc is an AIM‑listed investing company focused on financial services and adjacent markets, backing early‑stage, pre‑IPO and special‑situation opportunities. It seeks exits within ~three years of investment where possible.


Frequently asked questions

Did Caledonian release news on 11 Nov 2025?
No. There were no new RNS for CHP today at the time of writing; trading appears driven by momentum/technical factors and recent disclosures from late October/early November.

What is the most recent CHP corporate action?
The 12.5 bn consideration shares for the AlbaCo share‑swap were admitted to AIM on 5 Nov 2025, taking total voting rights to ~115.77 bn.

Why is AlbaCo so important to CHP?
CHP’s refreshed strategy centres on financial‑services assets; AlbaCo is a cornerstone exposure and its capital raise and licensing are central to CHP’s investment case.


Editorial note & disclaimer

This article summarises publicly available information from regulated feeds and reputable financial outlets as of 11 Nov 2025. It is not investment advice. Micro‑cap AIM shares can be highly volatile and illiquid; always do your own research and consider professional advice.

Sources: FT market data and intraday analytics for CHP (price, MAs, volume, share count); recent RNS via Investegate/LSE (AlbaCo share‑swap, voting rights); AIM admission notice; UK market context from Reuters/Evening Standard.

Stock Market Today

  • Ross Stores Investment Gains: $1000 from 2014 Now Worth $4,384
    June 9, 2026, 10:24 AM EDT. A $1000 investment in Ross Stores (ROST) made in June 2014 would be worth $4,384 as of June 20, 2024, marking a 338.42% gain excluding dividends. Ross Stores, an off-price apparel retailer operating over 2,100 stores across the U.S., targets middle-income shoppers with goods priced 20%-70% below regular department store prices. The stock's performance outpaces the S&P 500's 180.02% gain and gold's 70.33% return in the same period. Analysts expect further upside due to strong customer demand and Ross's continued store expansion, with 26 new locations opened recently. The company's consistent earnings beats reinforce its market position in the competitive retail sector.

Latest articles

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
SpaceX launches 29 Starlink satellites from Florida; targets another 28 from Vandenberg today (Nov. 6, 2025)
Previous Story

SpaceX Launches 29 Starlink Satellites on Falcon 9, Breaking Florida’s Annual Launch Record — Nov. 11, 2025

Sky on Fire Tonight: Giant ‘Solar Canyon’ Aims 800‑km/s Wind at Earth—Northern Lights Could Ignite 15 U.S. States & Test Global Tech
Next Story

NOAA Issues G4 ‘Severe’ Geomagnetic Storm Watch for Nov. 12 After X5.1 Solar Flare — Northern Lights Possible as Far South as Indiana Tonight (Nov. 11)

Go toTop